Status:
RECRUITING
Ultrasound-guided Cryobiopsy of Mediastinal/Hilar Lymph Nodes
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
Aarau Cantonal Hospital (KSA)
Waid City Hospital, Zurich
Conditions:
Lung Cancer (NSCLC)
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
EBUS-guided cryobiopsy of mediastinal and hilar lymph nodes has shown to be a useful diagnostic tool to obtain tissue for histological analysis and further targeted therapies in lung malignancies. Due...
Detailed Description
EBUS-guided cryobiopsy of mediastinal and hilar lymph nodes has shown to be a useful diagnostic tool to obtain tissue for histological analysis and further targeted therapies in lung malignancies. Due...
Eligibility Criteria
Inclusion
- At least one mediastinal lesion or hilar 1 cm or longer in the short axis requiring diagnostic bronchoscopy
- Age between 18 and 90 years
- Written informed consent after participant's information
Exclusion
- Age \< 18 and \> 90 years
- Lacking ability to form an informed consent (including impaired judgement, communication barriers)
- Contraindication against bronchoscopy (e.g. co-morbidities)
- Mediastinal abscess or cyst
- Extraordinary blood supply of the lesion visualized by EBUS bronchoscope
- INR \> 1.5 or Thrombocytes \< 100 G/l
- Clopidogrel or other new antiplatelet drugs within 7 days before biopsy (salicylic acid alone allowed)
- Anticoagulation with NOAC within 48 hours before biopsy
- Pulmonary lesions suspicious of lung carcinoma
Key Trial Info
Start Date :
March 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT06921681
Start Date
March 7 2025
End Date
December 31 2029
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jürgen Hetzel
Basel, Switzerland